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We performed fetoscopy and skin biopsy on a 19-week 
fetus at risk for recessive dystrophic epidermolysis bulJosa 
(RDEB). Ultrastructural analysis of the tissue revealed der-
moly tic blister formation in the skin characteristic of the 
disease. To develop a biochemical test for Llse in antenata l 
diagnosis ofRDEB, we established skin fibroblast cultures 
from the 20-week aborted fetus. The colJ agenase produc-
tion by fetal RDEB fibroblast cultures was greater than 
seen in normal fetal fibroblast cultures. The concentration 
in culture medium from fetal RDEB cultures was 5.42 ± 
0.74 JLg/ml (mean ± SE) compared with 2.24 ± 1.11 
JLg/ml in normal adul t control cu ltures and 2.05 ± 0.61 
T he diseases coll ectively termed heredita ry epidermol-ysis bullosa (EB) are perhaps as many as 10-14 dif-fe rent genetic disorders in w hieh there is excess ive fra gility and blister formation of the skin and mucous membranes in response to minor trauma [1 ,2]. One 
of the most severe types, recess ive dystrophic epidermolys is bul-
losa (RDEB), is characterized by li fe long blistering with resultant 
scar formation, digital fusion , and major and minor joint con-
tractures. Because of blood and protein loss through the skin and 
mucosa l in volvement of the mouth and gas trointestinal tract, 
anemia and hypoproteinemia are usual and nutrition is poor. There 
is freq uently secondary growth retardation [1]. In some patients, 
cutaneous carcinomas develop in nonhealin g, chronic, ulcerative 
areas [3]. 
Cutaneous blister formation in RDEB is subepidermal in lo-
cation and is associated with degeneration of collagen [4] and 
hypoplasia o r absence of anchorin g fibril s [5-7]. Both in vivo 
[8,9] and in vitro [J 0, J J] data suggest that the morphologic evi-
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JLg/ml in cultures from patients with other genetic forms 
of epidermolysis bulJosa (p < 0.025). [n contrast, the con-
centration of collagenase in the fetal RDEB culture medium 
was not different fr0111 that seen in cell cultures from known 
patients with RDEB (5.34 ± 1.12 JLg/ml). Collagenase 
activity of the fetal RDEB medium was also increased -3.5-
fold . These data indicate that enhanced expression of col-
lagenase by feta l RDEB skin fibroblasts can serve as a bio-
chemical adjunct, and possibly an alternative, to morpho-
logic examination of tissue for antenatal diagnosis. J [lilIes, 
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dence for collagenolysis might be explained by in creased amounts 
of coll agenase. Indeed, cultured fibrob lasts from RDEB patients 
arc geneti call y unique among EB types for their capacity to syn-
thesize in creased amounts of a st ru cturally altered-as manifested 
by altered therma l stab ili ty , an altered apparent K", for Ca + + , 
altered pi , and an altered cyanogen bromide peptide map-but 
catal yticall y active, collagenase [12-15]. Therapeutic intervention 
in RDEB with agents that inhibit co llagenase synthesis , such as 
phenytoin [1 6) and 13- cis-retinoic acid [17 ,18] , has been beneficial, 
further suggesting that the coll agenase pla ys a pathophysiologic 
role in the disease [16,19-22). 
By employing both light and electron microscopic exa mination 
of bio psies obtained at the tim e of fctoscopy, RDEB can be di-
agnosed anten atally [23). However, morphologic changes ma y 
not always permit a clear diagnosis to be made. In addition, from 
a procedural standpoint, feta l skin biopsies are often taken in a 
"blind" fashion in the hope that the procedure itself will produce 
the characteristic cleavage within the dermis. Thus, we have sought 
a biochemical parameter th at might be employed as an alternative 
and lor as an adjunct to morphologic exa mination of the tissue. 
In th e present study we examined skin fibroblasts cu ltured from 
a fetus shown morphologicall y to have RDEB. We sought to 
answer 3 questions: (1) Is the enhanced expression of collagenase 
th at chara cterizes fibrobl as ts of typica l RDEB infants , children , 
and ad ults seen in fetal cells? (2) Are the putatively enhanced levels 
of collagenase significantly greater than expression of this enzyme 
by normal embryon ic and feta l cells ? (3) Mig ht express ion of 
coll agenase by fetal cells provide a further basis for genetic coun-
seling in kind reds at risk for EB? 
METHODS 
Case History The parents , a 29-year-old father and a 30-yea 1'-
old g ravida 3, para 1 mother, arc first cousins of Ecuadorian 
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descent. Her fi rst pregnancy, 6 yea rs prior to the currentl y re-
po rted pregnancy , resul ted in an in fa nt girl affected w ith RDEB. 
T he diagnosis was based on clini ca l fin dings and on li ght and 
electron mi crosco pic studies of skin biopsies o btained fro m the 
newborn in fa nt. T he chiJd is ali ve and has the classica l condition 
of m ultiple bullo us lesions w hich hea l w ith sca rrin g, contractures, 
mi tten-scarring of the hands, in volvement of the esophagus, and 
failu re to thri ve. T he parents elected to terminate a second preg-
nancy ea rl y in ges tation, because prenata l diagnosis was not ye t 
available to them . At the tim e o f the third pregnancy th e parents 
received geneti c counselin g. An extensive pedig ree o f the fa mily 
was ava il able and revea led no members, on either side, w ho were 
affected w ith EB. T hey were informed that the option fo r prenatal 
diagnosis by fetoscopy was now available, and they elected to 
undergo this procedure. 
At 19 weeks of ges tation fetosco py was perfo rm ed at the Mt. 
Sinai M edical Center in N ew York. Foll owin g i. v . sedation wi th 
diazepam and meperidine, the site of in serti on was in fi ltrated w ith 
a loca l anes thetic. T he fe toscope (Dyoni cs, Wo burn , M assachu-
setts) and ca nnul a were in serted for feta l visualiza tion. T he fe-
toscope was then removed and biopsy fo rceps (O lympus, N ew 
H yde Park, N ew Yo rk) introduced . Three skin sa mples were 
obtained and pl aced in 2% g lutaraldehyde/O. l M sodium caco-
dylate-buffered fi xati ve for li ght and electro n microscopy. The 
skin sa mples were shi pped at ambient tempera ture to Sea ttle for 
morphologic analysis. 
T he morpho l ~gi c studies revea led that the fe tus was affected, 
and w ith this in fo rma ti on the parents elected to te rmin ate the 
pregnancy 1 week after the fetosco py. Exa min ation of th e abo rtus 
revealed a fe male fetus of - 20 weeks ges tatio n. T he biopsy sites 
were hea led , bu t multiple bullous lesio ns were visible. N o other 
m alform ations were seen. Skin biopsies were obta ined fro m the 
abo rtus fo r biochemi cal and mo rph ologic studies . Sa mples for 
cell culture anal ys is were shipped in culture m edium to St. Lo uis. 
Samples for morphology were fi xed as described above and shipped 
to Sea ttle. 
Fibroblast Cultures Skin specimens used as a source for cont ro l 
fi broblas t cultures were obtained fro m 7 presumed normal aborted 
hum an embryos and fe tuses in the range of7-27 weeks es timated 
gesta tional age (EGA) through th e courtesy of the Central Lab-
o ratory fo r Human E mbryology at the Uni versity of Washin gton 
(Table I). Assessm ent of ges tational age was initiall y based on 
m atern al history and feta l foot length and refin ed by histo logic 
exa min ation of the epidermis [24]. As fur ther controls, cell strains 
fro m 3 no rm al adults were empl oyed . In additio n, fibrobl as t cul-
tures fro m 3 patients (age 1 day-4 yea rs) w ith typica l RDEB and 
from 4 patients (age 1 day-21 yea rs) with o th er geneti c types of 
EB were used for co mparison o f in vit ro collagenase expression 
(Table I). Cells we re subcu ltiva ted in disposa ble pl as ti c culture 
dishes or fl asks in D ulbecco's m odi fied Eagle's medium (DME M) 
conta ining 30 m M N-2-hydroxyeth ylpiperazine-N ' -2-eth anesul-
foni c acid (H EPES) bu ffer (pH 7.5), 10% fe tal ca lf serum , and 
200 uni ts of peni cillin , an d 200 J.Lg ofstrepto m ycin per ml at 37°C 
in a 95% O 2:5% CO2 atmosphere [25]. 
In experim ents to compare co lJ agenase ex pression in fe tal, no r-
mal adult , and E B fib roblas t cultures, skin fibrobl as ts were grown 
to confluence under ri gorously contro lled culture conditions [26,27]. 
T he serum-containing cultu re medium was then rem o ved , the 
cell layer was washed 3 tim es w ith prewa rm ed Hanks' balanced 
sa lt so lution, and serum- free D ME M was added to the cell layer. 
Following in cubation fo r 24 h, the culture medium was rem oved 
and assayed for collagenase activity and/or immuno reactive col-
lagenase pro tein (sec below). T he cell la.yer was washed w ith 
phosphate-buffe red saline and hydrolyzed at 37°C in 0. 5 M N aOH 
fo r protein determi nation [28]. [n each experiment to exa mine 
collagenase exp ression in the cells of the fetus at ri sk, bo th known 
RDEB cells (presumed pos itive fo r excessive collagenase pro-
duction) and nega ti ve (norm al cells and cells fro m other EB ty pes 
pres um ed to have no enhancem ent of coll agenase synth esis) con-
tro l cul tures w ere included . 
T H E J OU RN AL OF IN V ESTIGATIV E DERM AT O LOGY 
Table I. Hum an Skin Fibroblas t Strains 
Cell Strain 
Norm al controls 
WUN 83806 
WUN 81711 
WUN 79425 
WUN 5223 
WUN 5165 A 
WUN 5165B 
WUN 5792 
WUN 5470 
WUN 5829 
WUN 6167 
Sex 
M 
F 
F 
Unknown 
Unknown 
Unk now n 
Unknown 
Unknown 
M 
M 
Recessive dys trophic epidermolys is bullosa 
WUE 7611 4 M 
WUE 78311 M 
WUE 84923 M 
O ther epidermolysis bullosa" 
WU E 7567 
WU E 7559 
WUE 78310 
WU E 7611 2 
Fetlls at ri sk 
WUFE 84934 
M 
F 
M 
M 
F 
Age 
28 years 
25 years 
13 years 
7 weeks EGA 
7 weeks EGA 
7 weeks EGA 
11 weeks EGA 
11 weeks EGA 
15 weeks EGA 
27 weeks EGA 
4 years 
1 day 
1 year 
4 years 
21 years 
1 day 
1 day 
20 weeks EG A 
·'Other EB cell types employed were do min ant EB simplex (W U E 7567). dom-
inallt dystrophic EB (WUE 7559). and recessive junctional EB (W UE 783 10 and 
WUE 76 11 2) . 
Immunoreactive Collagenase Immunoreactive collagenase 
pro tein w as quantitated using the enzym e-linked immunosorbent 
assay (ELI SA) fo r colJ agenase previously repo rted [29]. T he en-
zy me used for developing the standard curve was human skin 
coll agenase purified by the method of Stri cklin et al [30]. This 
enzy m e was also used to eli cit fun ctionall y specific antiserum to 
the enzy me [31]. 
Co lagenase Activity Human skin procollagenase in the cul-
ture medium was activated pro teolytica ll y w ith trypsin as de-
scribed previously [25]. Fo r each enzym e preparation, a range of 
trypsin concentrations (0.2-5 J.Lg o f trypsin /1 00 J.L1 enzyme sam-
ple) was employed to ensure that m aximal collagenase activity 
was measured. After preincubatio n with trypsin fo r 10 min at 
37°C, at leas t a 5-fold mol ar excess o f soybean trypsin inhibitor 
was added to inhibit furth er activity . Each mix ture was then 
assayed at 37"C in 0.05 M Tris-HC I (pH 7.5) with 10 mM CaC h 
usin g nati ve reconstituted [14C ]-glycine-labcled coll agen fib rils 
conta ining - 3000 cpm /substrate gel [32]. 
RESULTS 
Fetoscopy was ca rried out at 19 weeks o f ges tatio nal age. As 
shown in Fig 1, the light micrograph , th e tissue sample w as 
adequate fo r diagnos tic exa mination . T here was separation at the 
derm al-epiderm al junction , resulting in a subepiderm al blister 
ca vity . Further exa min ation of the skin biopsy by transmission 
electron microscopy revealed intac t epiderm al basal cells with 
des tru ction of th e dermal connective tissue. The basa l lamina 
(lamin a densa) remained in th e roof of th e blister, indi catin g the 
dermolytic bull a fo rm ation typica l of RDE B (Fig 2). 
T o determine the potenti al usefulness of in vitro collagenase 
express ion in the antenata l diagnos is o f RDE B, w e es tablished 
fibroblast cultures from the skin of the 20- week RDEB abo rted 
fetus. Sin ce we have recentl y shown that collagenase expression 
is dependent upon EG A in no rmal embryos and fetuses [33], w e 
used cell s fro m individuals of varying EGA as controls fo r the 
20- week fetus at risk (Fi g 3). As shown ea rlier in the normal fetal 
cell cultures, collagenase expression w as signifi cantly correlated 
w ith EG A and form ed a linear regression line (r = 0.985; P < 
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Figure 1. Light micrograph of a section through a skin biopsy obtained 
by fetoscopy from a fetus of 19 weeks gestational age at risk for RDEB. 
The epidermis (bl is separated from the dermis (0) by an extensive blister 
cavity (asterisk). Deep portions of the hair follicles remain in the dermis. 
x 125. 
Figure 2. Transmission electron micrograph of the basal epidermal cells 
(keratinocytes-K) in the blister roof evident in a feta l skin biopsy sa mple 
obtained by fctoscopy from a 19-week-old fetus at risk for RDEB. The 
basa l lam ina (nI.,.O fl/) remains with the epiderqlis. The connective ti ssue 
of the prox imal papillary dermis is destroyed and replaced by blister Auid 
(asterisk) . . X 10,000 
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0.02) that could be extrapolated to -6 weeks EGA for the onset 
of collagenase synthesis by embryonic skin fibro blas ts [33]. Also 
as shown earlier, the m ean (± SE) immunoreactive collagenase 
concentration at 27 weeks EGA was no t significantly different 
from that seen in the cultures derived from norm al adults. 
In contra st, in 5 experiments in vitro coll agenase expression of 
the RDEB fetal cells was 5.42 ± 0.74 ILg of immunoreactive 
coll agenase per ml co mpared with 2.24 ± 1.11 ILg/ml in the 
no rmal adult control cultures and 2.05 ± 0.61 p.g/ml in cultures 
derived from patients with other genetic forms ofEB (p < 0.025). 
The individual collagenase values fro m the RDEB fetal cells were 
higher th an those of all of the normal fetal control cultures except 
that of one of 5 normal cultures taken fro m 27 w eeks EGA. In 
th~ sa m e experiments , as positive con trols, we employed cell 
strains from 3 patients with typical cl ini cal, histologic, and ul-
tras tructural features ofRDEB (Fig 3). In this case, the collagenase 
con cen~ra tion s of the fetal RDEB fibrobla sts were fundamenta ll y 
identical to those seen in the known RDEB cultures th at served 
as positive controls in which the collagenase concentration was 
5.34 ± 1.12 ILg/ml (p = N S co mpared with the 20-week RDEB 
aborted fetal cells) . 
To document further the increase in coll agenase production by 
the fetal RDEB cells, we m easured coll agenase activity (Table II). 
Compared with the activity seen in normal adu lt celJs and in 
dominant dys trophic EB cells (mea n ± SE = 1712 ± 69 cpm) 
the activity of the known RDEB cells was > 2-fold increased and 
the RDEB fetal cell collagenase activity was -3. 5-fold enhanced. 
In this same experiment, there was a parallel , but not precisely 
equal , increase in immunoreactive pro tein in the RDEB cells only. 
Since these cells have been shown to express norm al amounts of 
a specifi c collagenase inhibitor [34,35J (data not shown) , these 
results suggest so me activity has been lost as a result of the known 
in vitro labi lity of the enzyme [14,15] . 
DISC USSION 
Am ong the genetic types of EB, RDEB is perhaps the one as-
sociated w ith the most varied and profound morbidity [1 ,2]. Be-
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Figure 3. Collagenase expression by fibroblasts cultured from a fetus at 
risk for RDEB. Norm al human skin fetal fibroblasts (solid circles) and 
RDEB feta l fibroblasts (ope/l circle) were placed in serum-free medium for 
24 h after which the collagenase concentration was determined by ELISA. 
Normal adult control skin fibroblast cultures (not shown) were also in-
cluded and had 2.24 ± 1.11 JLg of immunoreactive colla genase per ml. 
Data 3're expressed as mean ± SE. For the content of norm al fetal cultures 
the coeffi cient correlation is .. = 0.985 (p < 0.02) . 
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Table II. Collagenase Activity and Immunoreactive Prote in in Fibroblas ts o f Fetus at Ri sk fo r Recessive Dystrophic 
E piderm olys is Bullosa (RDEB) 
Collagenase Acti vity" Immunoreactive Pro tein" 
Cul ture cpm/ ml Percent of Control JLg/ ml Percent of Contro l 
Normal contro l and other EB 
WUN 83806 1643 100 1. 23 100 
WUE 7559 1781 100 1.28 100 
Recess ive dys trophic EB 
WUE 78311 4357 254 10.24 813 
WUE 76114 3557 208 5.21 41 3 
Fetus a t risk 
WU FE 84934 6029 352 10.98 871 
"Coll agenase activ ity represents the cp m, l '4C lcoll agcn solubilized above bbnk durin g a 5-h assay at 37°C. Percent of C0I1 [ [ 9 1 was ca lcul ated as the in crease over the mean 
(1712 cpm) acti vity of the norm al and other EB coll agenase preparations. 
' Im munoreactive protein concentrat ion was determined by ELISA. Percent of co ntrol was ca lculated as the increase over the mea n (1. 26 ,",g/ ml) conccntrat ion of the 
normal and other EB colb.gcnasc preparatio ns. 
cause of this, methods fo r antenatal diagnosis have been sought. 
An additional consideration, however, is that the clini cal and 
ul tras tructu ra l pheno types o f RDEB patients may overlap w ith 
th ose of o ther form s o f EB, pa rticul arl y th e albo papulo id fo rm 
of do min ant dys trophi c EB [1 ,2,36). Thus, in the absence of a 
fa mil y history indica tin g a do minant Ill o de o f inheritance, it Illay 
be im possible on cl inical and hi sto logic g rounds to determine the 
precise geneti c type of EB in a spo radic pati ent w ith derm o ly tic 
blisterin g. T hi s in turn would prevent adequa te genetic coun selin g 
fo r members of the kindred at ri sk. 
O ur own stud ies [8, 12, 13), as well as th ose in o ther labo rato ries 
[9, 11 ,37-39] , showing an increase in bo th in vivo and in vitro 
collagenase sy nthesis in RDEB, wo uld seem to offer an addi-
tional-in this case, biochemical-para m eter to draw upon. Fur-
therm ore, we have recently dem onstrated th at coll agenase expres-
sion by embryonic and fetal skin fibrobl as ts is dependent o n EGA 
until nea r the end of the second trimester when in vit ro concen-
tra tions of collagenase approximate those found in normal adult 
fi bro blas t cultures [33]. T hus, it see med th at we could legitimately 
test the po tential usefuln ess of enhanced expression of coll agenase 
as an in v itro an tenatal pheno typic m arker fo r RDEB. 
To acco mplish this, we required a positive m o rpho logic di-
agnosis in a fetus at ri sk fo llowed b y te rmination o f the pregnancy 
w ith tim ely recovery of tissue fo r es tablishing cell cultures . T he 
present case fulftlled both criteria. It is impo rtant to emphasize 
that we did no t feel ethicall y justified in perfo rmin g additional 
b io psies for es tablishin g cell cultu res at the time of fetosco py, 
sin ce the po tential Ll sefuln ess of such a tes t had no t ye t been 
es tablished. 
By employing skin fibro blas ts fro m th e 20-week RDEB fetus 
we have shown th at no t only is collagenase expression greater 
than anticipatecj fo r no rm al fetal cells at a comparable stage o f 
ges tation, but that it is signjfi cantly g reater than seen in either 
no rm al adult ceps o r in cells fro m patients of o ther geneti c types 
of EB. Conversely, synthesis o f collagenase is fund am entally 
identica l to th at seen in th e cultures of known patients with RDEB 
(Fig 3, Ta ble II). T hese o bservati ons, thus, sho uld enable us to 
utilize enhanced collagenase expression , at least as an adjun ct, if 
no t an alternative, to m orphologic examination o f fetal ti ssue. 
T he avail abili ty o f such a tool should further allow the clinician 
to distin guish dominant and recessive dys tro phi c form s o f EB 
and provide improved coun selin g. 
Finally, these studies raise the possibility of employing cultured 
amnio tic fluid cells to assess coll agenase synthesis. Although such 
studies were not perfo rm ed in ·the present case, p revious exa m-
ination of amnio tic fluid cells revealed significant d onal diversity 
in coll agenase expression (E. A . Ba uer, unpublished o bservation). 
T his suggests th at mixed amnio tic fluid cultures are signifi cantly 
mo re heterogeneous than cultured fe tal skin fibroblas ts. Thus, it 
seem s unlikely at present that amnio tic fluid cells can be used fo r 
biochemica l analys is in th e diagnosis of RDEB. 
We th allk Mr. S tall ley White, Ms. Isabella j alliry , MI' . Robert Ullderl/lood, 
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